Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea · Delayed Price · Currency is KRW 4,700.00
-110.00 (-2.29%)
At close: Jul 18, 2025, 3:30 PM KST
Korea Arlico Pharm Company Description
Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea.
It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases.
Korea Arlico Pharm Co.,Ltd. was founded in 1992 and is headquartered in Seoul, South Korea.
Korea Arlico Pharm Co.,Ltd.
| Country | South Korea |
| Founded | 1992 |
| Industry | Pharmaceutical Preparations |
| Employees | 112 |
| CEO | Hang-Gu Lee |
Contact Details
Address: Alico Pharmaceutical Building Seoul South Korea | |
| Phone | 82 2 585 0004 |
| Website | arlico.co.kr |
Stock Details
| Ticker Symbol | 260660 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hang-Gu Lee | Chief Executive Officer |